Literature DB >> 10471435

Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?

M Weih1, K Kallenberg, A Bergk, U Dirnagl, L Harms, K D Wernecke, K M Einhäupl.   

Abstract

BACKGROUND AND
PURPOSE: Ischemic tolerance has been extensively studied in experimental models of heart and brain ischemia. While there is some clinical evidence of ischemic tolerance in the heart, it is not known whether the same is true for the human brain.
METHODS: We conducted a retrospective case-control study in 148 stroke patients with and without antecedent TIA.
RESULTS: Despite no significant differences in baseline characteristics, independence (Rankin scale score of 0 to 1) and favorable outcome (Glasgow Coma Scale score of 5) were significantly associated with prior TIA in univariate analysis. After correction for other cardiovascular risk factors, TIA before stroke also was an independent predictor of mild stroke (Canadian Neurological Scale score of > or= 6.5) in multivariate models (absolute difference 21.6%; P=0.01).
CONCLUSIONS: Assuming that a TIA represents an adequate stimulus to elicit ischemic tolerance, our results suggest that ischemic tolerance might occur in the human brain.

Entities:  

Mesh:

Year:  1999        PMID: 10471435     DOI: 10.1161/01.str.30.9.1851

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  67 in total

Review 1.  The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

Authors:  B McLaughlin
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

2.  Gene expression analysis to identify molecular correlates of pre- and post-conditioning derived neuroprotection.

Authors:  Shiv S Prasad; Marsha Russell; Margeryta Nowakowska; Andrew Williams; Carole Yauk
Journal:  J Mol Neurosci       Date:  2012-04-01       Impact factor: 3.444

3.  Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke.

Authors:  Hagen Kunte; Sein Schmidt; Michael Eliasziw; Gregory J del Zoppo; J Marc Simard; Florian Masuhr; Markus Weih; Ulrich Dirnagl
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

Review 4.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 5.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 6.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

Review 7.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

8.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 9.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 10.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.